Blogs (6)

Nanrilkefusp alfa is a Selective and Potent Agonist Fusion Protein of IL-15.

Nanrilkefusp alfa is a selective and strong IL-15 agonist. It inhibits tumor metastasis and viability by activating natural killer (NK) cells.
BLU2864 is An Orally Active PRKACA Kinase Inhibitor

BLU2864 is an orally active ATP-competitive PRKACA inhibitor. BLU2864 can be used in cancer and polycystic kidney disease research.
Axitinib is a Multi-Targeted Tyrosine Kinase Inhibitor

Axitinib is a multi-targeted tyrosine kinase inhibitor and potently inhibitor VEGFR1, VEGFR2, VEGFR3 and PDGFRβ.
CPTH2 is a Potent Histone Acetyltransferase (HAT) Inhibitor

CPTH2 is a potent histone acetyltransferase (HAT) inhibitor and selectively inhibits the acetylation of histone H3 by recombinant human Gcn5.
BI-4924 is a Selective PHGDH Inhibitor

BI-4924 is a lipophilic and highly plasma protein bound selective phosphoglycerate dehydrogenase (PHGDH) inhibitor (IC50=3 nM) with excellent microsomal.
SBI-0206965, a ULK1 Inhibitor, Triggers Apoptosis by Preventing Autophagy and PPP Flux

SBI-0206965 is a selective and cell permeable autophagy kinase ULK1 inhibitor with IC50s of 108 nM for ULK1 and 711 nM for the highly related kinase ULK2 .

Name
Email *

	Sorry, but the email address you supplied was invalid.